Developer docs
API playgroundTry for free, no card

Search company profiles

Protein Stable

Full company profile

uuid002mhh5

Namestring
Protein Stable
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Protein Stable is a private UK-based biotechnology company headquartered in Leatherhead, founded in 2020. The company provides services across four core areas of biologics development: drug discovery, screening, formulation, and protein characterisation. These capabilities position Protein Stable as a contract research / service provider to biopharma clients developing protein-based therapeutics, where stability, developability, and characterisation are critical bottlenecks.

The company's underlying offering combines wet-lab protein sciences with service delivery — helping clients assess and optimise the stability and behaviour of protein candidates during discovery and pre-formulation stages. Operationally, Protein Stable runs as a small, privately held firm with 11–50 employees and is led by CEO Tim Flanagan. The exact technical platforms, instrumentation, and proprietary methodologies are not disclosed in the available source data, and the company's website was inaccessible at the time of data collection.

Protein Stable's business model is service-based, with revenue derived from project-based or contract work for biopharma customers. No pricing model, customer segments, or named accounts are disclosed, and no funding rounds, investors, or revenue figures are publicly available. Ownership and control structure are likewise undetermined from the available data, leaving the company's commercial scale, customer base, and capital position largely opaque.

Short descriptiontext

Protein Stable is a UK-based private biotech founded in 2020 that provides drug discovery, screening, formulation, and protein characterisation services to biopharma clients developing protein-based therapeutics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLeatherhead, United Kingdom
HQ citystring
Leatherhead
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
protein characterization services, drug discovery services, biologics formulation development, protein stability screening, biopharmaceutical analytical services
Industry2 codes
PRIMARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Drug Discovery and Protein Characterization Services
Social media profiles2 records
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Protein Stable is a contract research/services biotech that delivers protein characterization, drug discovery and screening, and biologics formulation development work for biopharmaceutical clients. The firm operates laboratory-based projects that evaluate protein stability and behavior to support therapeutic candidate selection and formulation.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1Drug Discovery Services
CategoryDrug Discovery Services
2Protein Screening Services
CategoryProtein Characterization Services
3Formulation Development Services
CategoryFormulation Development Services
4Protein Characterization Services
CategoryProtein Characterization Services
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global testing and contract laboratory group with significant biopharma and protein characterisation service lines. Comparable to Protein Stable on analytical and protein characterisation work, but operates as a broad incumbent across many testing categories.

2Absolute Antibody
TypeDirect peer
Description

Specialist provider of recombinant antibody and protein engineering, production, and characterisation services. Highly comparable to Protein Stable on the protein engineering/screening and biologics characterisation axes.

TypeOthers
Description

Supplier of bioprocessing equipment, consumables, and analytical tools used in protein and biologics workflows. Adjacent to Protein Stable as a key enabling vendor whose products underpin the protein characterisation and formulation work Protein Stable performs.

TypeDirect peer
Description

UK CRO offering integrated drug discovery services including screening, medicinal chemistry, and protein-related assay work. Comparable to Protein Stable on the small-molecule and protein-focused drug discovery and screening offering.

TypeDirect peer
Description

UK-headquartered biologics CDMO/CRO offering discovery, formulation, and analytical/characterisation services for biologics. Comparable to Protein Stable as a UK-based integrated biologics services provider, though operating at significantly larger scale.

TypeBroad incumbent
Description

Global biologics CDMO with end-to-end discovery, development, and manufacturing services. Comparable to Protein Stable on the integrated biologics services model, but as a multinational incumbent with very different scale and capital base.

TypeBroad incumbent
Description

Global CRO with extensive biologics, discovery, and characterisation capabilities. Comparable as a broad incumbent offering the same discovery, screening, and protein services categories that Protein Stable addresses, but at vastly greater scale and geographic reach.

TypeDirect peer
Description

Larger UK-based drug discovery CRO providing screening, medicinal chemistry, and DMPK services. Comparable to Protein Stable as a UK-headquartered discovery CRO serving biotech and pharma clients with multi-disciplinary scientific teams.

TypeDirect peer
Description

UK-based specialist CRO providing protein production, characterisation, and biophysics services. Directly comparable to Protein Stable on protein characterisation, formulation, and biologics-focused discovery support, with a similarly focused operating model.

TypeBroad incumbent
Description

Global biologics CDMO with upstream discovery support, formulation, and analytical/characterisation services. Comparable to Protein Stable across most of its service stack, but as a much larger, publicly listed broad incumbent.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Protein Stable

Drug Discovery and Protein Characterization Servicesproteinstable.com

Protein Stable is a UK-based private biotech founded in 2020 that provides drug discovery, screening, formulation, and protein characterisation services to biopharma clients developing protein-based therapeutics.

What Protein Stable does

Protein Stable is a private UK-based biotechnology company headquartered in Leatherhead, founded in 2020. The company provides services across four core areas of biologics development: drug discovery, screening, formulation, and protein characterisation. These capabilities position Protein Stable as a contract research / service provider to biopharma clients developing protein-based therapeutics, where stability, developability, and characterisation are critical bottlenecks.

The company's underlying offering combines wet-lab protein sciences with service delivery — helping clients assess and optimise the stability and behaviour of protein candidates during discovery and pre-formulation stages. Operationally, Protein Stable runs as a small, privately held firm with 11–50 employees and is led by CEO Tim Flanagan. The exact technical platforms, instrumentation, and proprietary methodologies are not disclosed in the available source data, and the company's website was inaccessible at the time of data collection.

Protein Stable's business model is service-based, with revenue derived from project-based or contract work for biopharma customers. No pricing model, customer segments, or named accounts are disclosed, and no funding rounds, investors, or revenue figures are publicly available. Ownership and control structure are likewise undetermined from the available data, leaving the company's commercial scale, customer base, and capital position largely opaque.

Protein Stable firmographics

Firmographics
Name
Protein Stable
Website
https://proteinstable.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Protein Stable is a UK-based private biotech founded in 2020 that provides drug discovery, screening, formulation, and protein characterisation services to biopharma clients developing protein-based therapeutics.
Ownership category
akta.pro rank

Protein Stable industry classification

Industry
Product category
Drug Discovery and Protein Characterization Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (541380)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing

Keywords

  • Protein characterization services
  • Drug discovery services
  • Biologics formulation development
  • Protein stability screening
  • Biopharmaceutical analytical services

Where Protein Stable is headquartered

Location

Headquarters

HQ city
Leatherhead
HQ country
United Kingdom
HQ region
Europe

Markets served

Protein Stable business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Protein Stable product offering

Product offering

Core offering

Protein Stable is a contract research/services biotech that delivers protein characterization, drug discovery and screening, and biologics formulation development work for biopharmaceutical clients. The firm operates laboratory-based projects that evaluate protein stability and behavior to support therapeutic candidate selection and formulation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Drug Discovery Services
  • Protein Screening Services
  • Formulation Development Services
  • Protein Characterization Services

Companies that use Protein Stable

Customer profile

Ideal customer profiles1 record

Protein Stable technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Protein Stable partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Protein Stable competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global testing and contract laboratory group with significant biopharma and protein characterisation service lines. Comparable to Protein Stable on analytical and protein characterisation work, but operates as a broad incumbent across many testing categories.
  • WuXi Biologics: Global biologics CDMO with end-to-end discovery, development, and manufacturing services. Comparable to Protein Stable on the integrated biologics services model, but as a multinational incumbent with very different scale and capital base.
  • Charles River Laboratories: Global CRO with extensive biologics, discovery, and characterisation capabilities. Comparable as a broad incumbent offering the same discovery, screening, and protein services categories that Protein Stable addresses, but at vastly greater scale and geographic reach.
  • Lonza: Global biologics CDMO with upstream discovery support, formulation, and analytical/characterisation services. Comparable to Protein Stable across most of its service stack, but as a much larger, publicly listed broad incumbent.

Direct peers

  • Absolute Antibody: Specialist provider of recombinant antibody and protein engineering, production, and characterisation services. Highly comparable to Protein Stable on the protein engineering/screening and biologics characterisation axes.
  • Domainex: UK CRO offering integrated drug discovery services including screening, medicinal chemistry, and protein-related assay work. Comparable to Protein Stable on the small-molecule and protein-focused drug discovery and screening offering.
  • Abzena: UK-headquartered biologics CDMO/CRO offering discovery, formulation, and analytical/characterisation services for biologics. Comparable to Protein Stable as a UK-based integrated biologics services provider, though operating at significantly larger scale.
  • Sygnature Discovery: Larger UK-based drug discovery CRO providing screening, medicinal chemistry, and DMPK services. Comparable to Protein Stable as a UK-headquartered discovery CRO serving biotech and pharma clients with multi-disciplinary scientific teams.
  • Peak Proteins: UK-based specialist CRO providing protein production, characterisation, and biophysics services. Directly comparable to Protein Stable on protein characterisation, formulation, and biologics-focused discovery support, with a similarly focused operating model.

Others

  • Sartorius: Supplier of bioprocessing equipment, consumables, and analytical tools used in protein and biologics workflows. Adjacent to Protein Stable as a key enabling vendor whose products underpin the protein characterisation and formulation work Protein Stable performs.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Protein Stable social profiles

Digital presence

Protein Stable financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Protein Stable leadership team

Management profile

Number of profiles

Profiles1 record

Protein Stable funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Protein Stable M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Protein Stable

What does Protein Stable do?

Protein Stable is a contract research/services biotech that delivers protein characterization, drug discovery and screening, and biologics formulation development work for biopharmaceutical clients. The firm operates laboratory-based projects that evaluate protein stability and behavior to support therapeutic candidate selection and formulation.

When was Protein Stable founded?

Protein Stable was founded in 2020. It employs 11 to 50 people.

Where is Protein Stable based?

Protein Stable is headquartered in Leatherhead, United Kingdom, in the Europe region.

Who are Protein Stable's main competitors?

Broad incumbents on record are Eurofins Scientific, WuXi Biologics, Charles River Laboratories and Lonza. Direct peers are Absolute Antibody, Domainex, Abzena, Sygnature Discovery and Peak Proteins. Sartorius is listed as an others.

Does Protein Stable have an API?

No public API is recorded for Protein Stable.

What industry is Protein Stable in?

Protein Stable's product category is Drug Discovery and Protein Characterization Services. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales